Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae.
about
Pharmacokinetics of gatifloxacin in infants and childrenIn vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis.Pharmacodynamic assessment of ertapenem (MK-0826) against Streptococcus pneumoniae in a murine neutropenic thigh infection model.Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury.Bactericidal activities of methoxyfluoroquinolones gatifloxacin and moxifloxacin against aerobic and anaerobic respiratory pathogens in serum.Pharmacokinetics-pharmacodynamics of rifampin in an aerosol infection model of tuberculosis.Pharmacodynamics of moxifloxacin and levofloxacin at simulated epithelial lining fluid drug concentrations against Streptococcus pneumoniae.Pharmacodynamics of a novel des-F(6)-quinolone, BMS-284756, against Streptococcus pneumoniae in the thigh infection model.Pharmacodynamic assessment based on mutant prevention concentrations of fluoroquinolones to prevent the emergence of resistant mutants of Streptococcus pneumoniae.Vitreous penetration of orally administered gatifloxacin in humans.In vitro and in vivo pharmacodynamic properties of the fluoroquinolone ibafloxacin.
P2860
Q33856763-9A277ED5-599F-4C4C-AD53-AB8DDCF5B508Q34106465-0C4FD367-0C81-4F17-95EB-4FEEAC0817A7Q34112691-A3250318-3050-40F8-B36A-4C46713F78A1Q34680572-DE130BE7-99B5-466B-8283-560C1CE0C753Q34882995-51AC05D5-B2BF-4A43-9488-237F6BE68465Q35102656-57ECF8ED-2E70-421D-969B-5D2A153E708FQ37120372-5C4D92E6-219B-47C2-95E3-6DF5859CB509Q39746333-0296660D-779D-4CBD-A620-4A836E065B65Q41854694-D7C45A88-77C0-4F5F-BB25-1084201E0053Q43195705-A83C456B-29E7-4C7E-BD05-F8697CFDA175Q44251215-6B57EB8A-4B72-40C1-A234-9108B6D0064F
P2860
Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae.
@en
Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae.
@nl
type
label
Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae.
@en
Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae.
@nl
prefLabel
Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae.
@en
Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae.
@nl
P2093
P2860
P1476
Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae.
@en
P2093
C H Nightingale
D P Nicolau
H M Mattoes
M Banevicius
P2860
P304
P356
10.1128/AAC.45.7.2092-2097.2001
P407
P577
2001-07-01T00:00:00Z